| Date | Acquired company | Acquiring company | Amount | Related |
|---|---|---|---|---|
| 2015-08-31 | Naurex (USA - IL) | Allergan (Ireland) | $560 million and undisclosed milestone payments | CNS diseases |
| 2015-08-31 | Scioderm (USA - NC) | Amicus Therapeutics (USA - NJ) | $229 million | Rare diseases |
| 2015-08-28 | OTC brands from GSK (UK) | Perrigo (Ireland) | €200 million | |
| 2015-08-27 | Receptos (USA - CA) | Celgene (USA _ NJ) | $7.2 billion | Autoimmune diseases Inflammatory diseases |
| 2015-08-27 | Calibrium (USA - IL) | Novo Nordisk (Denmark) | undisclosed | Diabetes Metabolic diseases |
| 2015-08-27 | MB2 (USA - IN) | Novo Nordisk (Denmark) | undisclosed | Diabetes Metabolic diseasees |
| 2015-08-20 | Bio-Reference Laboratories (USA - NJ) | Opko Health (USA - FL) | $ 1.47 billion | CRO |
| 2015-08-20 | Sprout Pharmaceuticals (USA - NC) | Valeant Pharmaceuticals (Canada) | $1 billion in cash, plus a share of future profits based upon the achievement of certain milestones | Women health |
| 2015-08-19 | Kapa Biosystems (USA - MA) | Roche (Switzerland) | undisclosed | Technology - Services |
| 2015-08-17 | Cord Blood Registry®(CBR®) (USA - CA) | Amag Pharmaceuticals (USA - MA) | $700 million (€ 631 million) | |
| 2015-08-13 | GeneWEAVE (USA - CA) | Roche (Switzerland) | up to $ 425 million | Diagnostic |
| 2015-08-04 | Hospira (USA - IL) | Pfizer (USA - NY) | $17 billion | Generics Biosimilars |
| 2015-08-03 | Novartis’ influenza vaccine business (Switzerland) to be renamed Seqirus | CSL (Australia) | $275 million | Vaccines |
| 2015-08-03 | Foresight Biotherapeutics (USA - NY) | Shire (UK - USA) | $300 million | Ophtalmological diseases |
| 2015-08-03 | 51% equity share of Immuneering Corporation (USA - MA) | Teva Pharmaceutical (Israel) | undisclosed | Technology - Services Biomarkers |
| 2015-07-30 | Coretherapix (Spain) | Tigenix (Belgium) | € 6.7 million and up to €318.5 million | Cell therapy |
| 2015-07-28 | cCAM Biotherapeutics (Israel) | Merck&Co (USA - NJ) | up to $ 605 million | Cancer - Oncology |
| 2015-07-22 | Naturwohl Pharma (Germany) | Perrigo (Ireland) | Nutrition |
|
| 2015-07-06 | Oculeve (USA - CA) | Allergan (Ireland) | $125 million upfront payment and commercialization milestone payments related to Oculeve\'s lead development program OD-01 | Ophtalmological diseases |
| 2015-06-29 | Spinifex Pharmaceuticals (Australia - USA - CT) | Novartis (Switzerland) | undisclosed | CNS diseases |
